Valuation: DBV Technologies

Market Cap 704M 802M 655M 601M 1.13B 77.29B 1.15B 7.77B 3.04B 37.93B 3.01B 2.95B 131B P/E 2026 *
-4.85x
P/E 2027 * -16.6x
Enterprise Value 629M 716M 585M 537M 1.01B 69.01B 1.02B 6.94B 2.71B 33.87B 2.69B 2.63B 117B EV / Sales 2026 *
246x
EV / Sales 2027 * 9.7x
Free-Float
99.84%
Yield 2026 *
-
Yield 2027 * -
1 day-0.93%
3 months-0.93%
6 months+9.23%
Current year+9.23%
Current year 4.26
Extreme 4.26
4.8
1 year 3.9
Extreme 3.9
4.8
3 years 0
Extreme 0.0001
4.8
5 years 0
Extreme 0.0001
4.8
10 years 0
Extreme 0.0001
82.48
Manager TitleAgeSince
Chief Executive Officer 66 29/11/2018
Director of Finance/CFO 56 06/11/2023
Chief Operating Officer - 01/12/2023
Director TitleAgeSince
Director/Board Member 51 21/10/2015
Director/Board Member 62 21/06/2016
Director/Board Member 60 15/06/2017
Change 5-day change 1-year change 3-year change Capi.($)
-0.93%-.--% - - 802M
+0.45%+2.80%+54.73%+21.89% 324B
-0.07%+2.09%+23.58%-11.37% 68.88B
+1.35%+5.29%+40.68%+91.38% 9.72B
+0.93%-1.38%+2.01%-3.34% 8.37B
+1.13%+1.51%-21.44%-1.35% 4.32B
+4.90%+5.79%-38.81%+23.85% 3.83B
-4.00%+0.71%-5.66%+13.37% 3.62B
-2.10%-3.83%+37.58%+52.58% 2.68B
-4.07%-2.45%-8.03%-16.98% 2.04B
Average -0.24%+1.24%+9.40%+18.89% 47.47B
Weighted average by Cap. +0.36%+2.17%+45.82%+17.33%

Financials

2026 *2027 *
Net sales 2.56M 2.92M 2.38M 2.19M 4.11M 281M 4.17M 28.25M 11.05M 138M 10.94M 10.71M 477M 70.24M 80M 65.34M 59.95M 113M 7.71B 114M 775M 303M 3.78B 300M 294M 13.09B
Net income -174M -198M -162M -149M -279M -19.1B -284M -1.92B -751M -9.38B -744M -728M -32.45B -116M -132M -108M -99M -186M -12.73B -189M -1.28B -500M -6.25B -496M -485M -21.62B
Net Debt -75.46M -85.95M -70.2M -64.41M -121M -8.28B -123M -832M -326M -4.06B -322M -316M -14.07B -22.7M -25.86M -21.12M -19.38M -36.42M -2.49B -36.97M -250M -97.94M -1.22B -96.99M -94.95M -4.23B
Logo DBV Technologies
DBV Technologies specializes in developing solutions for diagnosing and treating food allergies (primarily to peanuts and cow's milk) using a patch (Viaskin®) that administers active ingredients into the top layers of the skin.
Employees
170
Date Price Change Volume
23/07/26 $0.000000 - 125,000
Trader
Investor
-
Global
-
Quality
-
ESG MSCI
-
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
4
Last Close Price
2.380EUR
Average target price
3.800EUR
Spread / Average Target
+59.66%

Quarterly revenue - Rate of surprise